Multiple myeloma cell therapy Abecma is the lone remaining asset of 2seventy Bio, which spun out from Bluebird Bio ...

Bristol-Myers Squibb acquires 2seventy bio for $286M, marking the end of a once-promising biotech. Check out if this is a ...

The deal comes after a challenging few years for 2seventy bio, which had divested research programmes in recent years.

The deal caps a turbulent three years for 2seventy bio. The company served as the oncology business of Bluebird Bio until Bluebird spun out 2seventy in 2021.

The deal ends 2Seventy’s short run as an independent company, during which it restructured, sold off research and lost nearly ...

Abecma made $406 million in 2024, of which BMS paid $43 million to 2seventy bio as part of their profit-sharing agreement.

We recently compiled a list of the 15 Best EV Stocks To Buy According to Billionaires. In this article, we are going to take ...

The Arizona bus envelops you in warmth and calmness with its organic design that blends natural materials, handcrafted ...

Signs waved in the air, and car horns blared in support as more than 150 people marched down Grand Avenue in Glenwood Springs ...

This Saturday (March 11th), Bones and three of country music’s top hitmakers will come together for a Writers’ Round that ...

Watch an astonishing transformation as this rare Blue Bird Rocket Car lighter undergoes a complete restoration! Layers of rust, tarnish, and scratches are carefully removed, revealing its original ...

When it comes to choosing a reliable used car, don't use conjecture and reputation—depend on data. The auto industry analysts at J.D. Power have exactly that, compiling their findings in their ...